The Enterprise Value as of November 2024 (TTM) for Paratek Pharmaceuticals, Inc. (PRTK) is 351.99M

According to Paratek Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 351.99M. This represents a change of 0.43% compared to the average of 350.48M of the last 4 quarters.

Paratek Pharmaceuticals, Inc. (PRTK) Historical Enterprise Value (quarterly & annually)

How has PRTK Enterprise Value performed in the past?

The mean historical Enterprise Value of Paratek Pharmaceuticals, Inc. over the last ten years is 244.78M. The current 351.99M Enterprise Value has changed 14.28% with respect to the historical average. Over the past ten years (40 quarters), PRTK's Enterprise Value was at its highest in in the September 2017 quarter at 713.27M. The Enterprise Value was at its lowest in in the March 2014 quarter at 12.49M.

Paratek Pharmaceuticals, Inc. (PRTK) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Paratek Pharmaceuticals, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Paratek Pharmaceuticals, Inc. (PRTK) Average Enterprise Value

How has PRTK Enterprise Value performed in the past?

The current Enterprise Value of Paratek Pharmaceuticals, Inc. (PRTK) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Paratek Pharmaceuticals, Inc. (PRTK) Enterprise Value vs. Peers

How is PRTK’s Enterprise Value compared to its peers?

Paratek Pharmaceuticals, Inc.’s Enterprise Value is greater than Selecta Biosciences, Inc. (69.24M), less than Corvus Pharmaceuticals, Inc. (570.78M), greater than Immutep Limited (270.34M), less than Icosavax, Inc. (713.87M), less than Lyra Therapeutics, Inc. (0), greater than Equillium, Inc. (23.90M), greater than HOOKIPA Pharma Inc. (10.24M), greater than LianBio (-36166707.00), greater than Jasper Therapeutics, Inc. (-66141903.00), greater than Affimed N.V. (240.35M), greater than Leap Therapeutics, Inc. (43.76M), greater than Adaptimmune Therapeutics plc (35.26M), greater than Aptose Biosciences Inc. (84.53M), greater than null (14.43M),

Build a custom stock screener for Paratek Pharmaceuticals, Inc. (PRTK) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Paratek Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Paratek Pharmaceuticals, Inc. (PRTK) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Paratek Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.